news publications resources about us management board of directors jobs contact us home research technology platform research projects partnerships newsroom news publications resources about us management board of directors jobs contact us modeling disease . accelerating cures . our mission stem cell theranostics is a precision medicine focused biotechnology company developing genetically targeted therapies for heart failure . the impact of heart failure heart failure is a serious and growing medical concern . the global economic burden of heart failure is a staggering 110b . genetic heart failure affects 1 in 500 people and touches the lives of nearly everyone . still there are no approved drugs that treat the underlying causes of genetic heart disease . additionally drug induced heart failure which has a genetic basis is responsible for 28 % of drug withdrawals . there is a critical need for translational preclinical models that address specific pathophysiology based on a patient s genetic profile . through our exclusive relationship with the stanford cardiovascular institute we have built a discovery platform that can be used to develop genetically targeted therapies and simultaneously assess cardiotoxicity . discover more . latest news how disease cardiomyocytes impact drug discovery isscr 2016 6 13 2016 interested in developing cardioprotective drugs 5 19 2016 stem cell theranostics loves the 2016 madison heart ball 1 26 2016 view all news copyright 2016 stem cell theranostics inc. privacy policy terms and conditions contact us